Institutional investors purchased a net $3.2 million shares of CPHD during the quarter ended September 2014 and now own 107.89% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MASSACHUSETTS MUTUAL LIFE INSURA... Bought 9.5 Thousand shares of Cepheid
RATHBONE INVESTMENT MANAGEMENT L... Bought 4.4 Thousand shares of Cepheid
STATE TEACHERS RETIREMENT SYSTEM... Bought 1.6 Thousand shares of Cepheid